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Introducing The Lancet Global Health
I am delighted to introduce the inaugural issue of 
The Lancet Global Health. It is very likely that you are 
reading this online, this being an online-only journal, 
although we have also printed this ﬁ rst issue in order 
to showcase the journal to readers of The Lancet. What 
is certain is that, in accessing this article, and all the 
other articles in this journal, you will have met with no 
registration barrier or paywall, for this is also an open-
access journal—the ﬁ rst Lancet journal so-designated. 
All the articles remain the property of the authors, and 
reuse by others is permitted under a variety of Creative 
Commons licences, from the most restrictive to the 
most liberal, according to authors’ own preferences. 
The journal’s gestation began with a call for papers 
back in March, and the subsequent inﬂ ux of high-quality 
submissions—from Pakistan, South Africa, Australia, 
Egypt, Nigeria, Canada, India, Italy, Laos, the USA, China, 
the UK, Uganda, the Netherlands, Kenya, Switzerland, 
and Malawi—has been wonderful to see. More papers 
from South America would be welcome.
This month’s issue contains a delightfully diverse 
selection of that research, together with Comments 
and Correspondence. The ﬁ rst two research papers 
complement the recent Lancet Series on maternal 
and child nutrition. Gretchen Stevens and colleagues’ 
systematic analysis shows how the prevalence of anaemia 
in women and children has changed since the mid-
1990s, with a slow decline overall but little improvement 
in some regions such as south Asia and central and west 
Africa. The ﬁ ndings provide a good baseline from which 
to work towards WHO’s global target to reduce anaemia 
in women by 50% by 2025. Continuing the global 
estimates theme, Anne C C Lee and colleagues put a 
ﬁ gure (32·4 million, or 27% of all livebirths) to the burden 
of intrauterine growth restriction in 138 low-income 
and middle-income countries. They go on to unpick the 
relative contribution of intrauterine growth restriction 
and preterm birth (being born either “too small or too 
soon”) to the prevalence of low birthweight (deﬁ ned 
as <2500 g). Regional diﬀ erences are striking: whereas 
65% of low-birthweight babies in south Asia are born at 
term and growth-restricted, the ﬁ gure is only 43% in sub-
Saharan Africa, where the majority of low birthweight is 
attributable to preterm birth. Lee and colleagues remind 
us that, although these numbers might be hard to reduce, 
plenty of low-cost care options exist for babies born too 
small or too soon (or both).
The third article in the issue represents a truly im-
pressive analysis with immediate practical relevance 
in low-income and middle-income countries. Nathan 
Congon and colleagues from across ten countries in Asia, 
Africa, and Latin America aimed to ascertain whether early 
(3-day) follow-up after cataract surgery was as accurate 
as standard 40-day follow-up in assessing the quality of 
surgery—a vital outcome measure in the evaluation of 
scaled-up cataract surgery programmes in high-burden 
areas. They found that it was. Early follow-up—ie, at 
hospital discharge—is vastly more convenient for patients 
who may have to travel long distances to the hospital 
(and half of whom never return for the 40-day follow up) 
and is likely to be much more cost-eﬀ ective for hospitals 
in terms of averting the need to chase up non-returners. 
The ﬁ nal research paper, from Laos, is an excellent 
example of a locally relevant paper with the sort of well 
designed, rigorous methodology that can (and should) 
be adapted to other settings worldwide. Mayfong 
Mayxay and colleagues aimed to uncover the main 
causes of non-malarial fever in the country and to try to 
suggest the best empirical treatment for such patients 
in the absence of any current recommendations. In 
identifying leptospirosis and scrub typhus as important 
treatable causes, the authors suggest that “Empirical 
treatment with doxycycline... could be an appropriate 
strategy for rural health workers in Laos”. This practical 
ﬁ nding, based on as solid an evidence base as is probably 
possible in such a challenging environment, is exactly 
the sort of work The Lancet Global Health is looking to 
support in the years ahead.
I encourage you to read all the Articles and their con-
textualising Comments, Richard Feachem and colleagues’ 
rousing unlinked Comment on malaria elimination, and 
the Correspondence letters on drug availability and public 
health in Pakistan. Do also visit our accompanying blog, 
which this week features a guest post by Sweden’s Global 
Health Ambassador Anders Nordström. I hope you enjoy 
this ﬁ rst issue and will use the site’s online commenting 
feature to let us know what you think.
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